Smart blood test aims to end blood pressure medication guesswork
NCT ID NCT07294794
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 'smart' blood test can help doctors choose the right blood pressure medication for each person. High blood pressure affects 1 in 3 adults and can lead to strokes or heart attacks. The trial will enroll 400 people across Europe to see if this personalized approach improves blood pressure control better than standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
INCLIVA, Biomedical Research Institute
Valencia, Spain
-
University Hospitals Birmingham, NHS Foundation Trust
Birmingham, West Midlands, United Kingdom
-
University Medical Center Hamburg-Eppendorf
Hamburg, Germany
-
University Medical Centre Utrecht
Utrecht, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Chatbot could put blood pressure control in Patients' hands
- Can a 5-Step chat help tame high blood pressure?
- Can artery scans reveal hidden damage from high blood pressure?
- CRISPR injection could rewrite the future of blood pressure control
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?